A retrospective review of sildenafil in the Australia and New Zealand Fontan registry: indications and treatment responses

Structured Abstract: Introduction: Rates of morbidity and mortality are high in the setting of Fontan physiology and effective medical therapies are not well-established. Clinical trials assessing phosophodiesterase-5-inhibitors, such as sildenafil, have not demonstrated major benefit in patients w...

Full description

Bibliographic Details

Published in:	International Journal of Cardiology Congenital Heart Disease
Main Authors:	Phidias Rueter, Mathilde O'Dell, David Celermajer, Clare O'Donnell, Julian Ayer, Yves d’Udekem, Rachael Cordina
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Subjects:	Congenital heart disease Fontan circulation Fontan failure Pulmonary vasodilator Sildenafil
Online Access:	http://www.sciencedirect.com/science/article/pii/S266666852400020X